Pharmocann Global Ltd announced a private placement of 111,100 common shares at a price of ILS 1.40 per share for gross proceeds of ILS 155,540 on April 16, 2024. The transaction included participation from new investor Simcha Yaakovovitz. The transaction has been approved by the board of directors of the company.